Top medtech successes in gastroenterology and metabolic diseases this year

On the reimbursement front, the AGA center – working with the other GI societies – works to put together rational reimbursement codes to reflect the new reality of the complexities of interventional procedures, he said.

“We have learned that you should not even be getting involved in commercial development of new devices without first running it through the filter of economics,” Dr. Pasricha said. A good idea for a new technology by itself is not sufficient, “especially now with all the cost constraints.”

Dr. Pasricha is a consultant, advisor, or cofounder for Apollo Endosurgery, Pentax, EndoGastric Solutions, Crospon, GI Cryo, Glyscend, Enterastim, and GI Scientific.

Ted Bosworth contributed to this report.